WO2002043662A3 - Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante - Google Patents

Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante Download PDF

Info

Publication number
WO2002043662A3
WO2002043662A3 PCT/US2001/044872 US0144872W WO0243662A3 WO 2002043662 A3 WO2002043662 A3 WO 2002043662A3 US 0144872 W US0144872 W US 0144872W WO 0243662 A3 WO0243662 A3 WO 0243662A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
calcium
linoleic acid
conjugated linoleic
composition containing
Prior art date
Application number
PCT/US2001/044872
Other languages
English (en)
Other versions
WO2002043662A2 (fr
Inventor
Adrianne Bendich
Original Assignee
Smithkline Beecham Corp
Adrianne Bendich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Adrianne Bendich filed Critical Smithkline Beecham Corp
Priority to MXPA03004817A priority Critical patent/MXPA03004817A/es
Priority to AU2002219949A priority patent/AU2002219949A1/en
Priority to JP2002545641A priority patent/JP2004514685A/ja
Priority to EP01998311A priority patent/EP1347745A4/fr
Priority to CA002427681A priority patent/CA2427681A1/fr
Publication of WO2002043662A2 publication Critical patent/WO2002043662A2/fr
Publication of WO2002043662A3 publication Critical patent/WO2002043662A3/fr
Priority to US11/325,085 priority patent/US20060105033A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne une composition à administration orale comprenant un mélange d'acide linoléïque conjugué (CLA), d'acide docosahexaénoïque 'DHA', de vitamine E, de vitamine C, de vitamine B6, de vitamine B12, d'acide folique et de calcium, sur un support adéquat. Ces compositions sont particulièrement utiles en tant que suppléments diététiques, administrés dans le but de réduire les facteurs de risque de maladie cardio-vasculaire, tels que des taux de cholestérol sérique et une tension artérielle élevés.
PCT/US2001/044872 2000-11-29 2001-11-29 Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante WO2002043662A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MXPA03004817A MXPA03004817A (es) 2000-11-29 2001-11-29 Composicion dietetica conteniendo acido linoleico conjugado y calcio para salud mejorada.
AU2002219949A AU2002219949A1 (en) 2000-11-29 2001-11-29 Dietary composition containing conjugated linoleic acid and calcium for improved health
JP2002545641A JP2004514685A (ja) 2000-11-29 2001-11-29 健康状態の改善のための共役リノール酸およびカルシウムを含有するダイエタリー組成物
EP01998311A EP1347745A4 (fr) 2000-11-29 2001-11-29 Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante
CA002427681A CA2427681A1 (fr) 2000-11-29 2001-11-29 Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante
US11/325,085 US20060105033A1 (en) 2000-11-29 2006-01-04 Dietary composition containing conjugated linoleic acid and calcium for improved health

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25389700P 2000-11-29 2000-11-29
US60/253,897 2000-11-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/325,085 Continuation US20060105033A1 (en) 2000-11-29 2006-01-04 Dietary composition containing conjugated linoleic acid and calcium for improved health

Publications (2)

Publication Number Publication Date
WO2002043662A2 WO2002043662A2 (fr) 2002-06-06
WO2002043662A3 true WO2002043662A3 (fr) 2003-01-23

Family

ID=22962148

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/044872 WO2002043662A2 (fr) 2000-11-29 2001-11-29 Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante

Country Status (6)

Country Link
EP (1) EP1347745A4 (fr)
JP (1) JP2004514685A (fr)
AU (1) AU2002219949A1 (fr)
CA (1) CA2427681A1 (fr)
MX (1) MXPA03004817A (fr)
WO (1) WO2002043662A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076695A1 (en) * 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US6743931B2 (en) * 2002-09-24 2004-06-01 Natural Asa Conjugated linoleic acid compositions
FR2847472B1 (fr) * 2002-11-22 2006-08-11 Synergia Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires
ITMI20030903A1 (it) * 2003-05-05 2004-11-06 Dietetic S P A Composizioni utili per il controllo del peso.
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
EP2014180A1 (fr) 2007-07-08 2009-01-14 Barilla G. e R. Fratelli S.p.A. Composition utile pour la réduction du risque cardiovasculaire et aliments l'utilisant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126960A (en) * 1997-03-27 2000-10-03 The Procter & Gamble Company Oral compositions having enhanced mouthfeel
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126960A (en) * 1997-03-27 2000-10-03 The Procter & Gamble Company Oral compositions having enhanced mouthfeel
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1347745A4 *

Also Published As

Publication number Publication date
JP2004514685A (ja) 2004-05-20
EP1347745A2 (fr) 2003-10-01
CA2427681A1 (fr) 2002-06-06
EP1347745A4 (fr) 2007-10-17
AU2002219949A1 (en) 2002-06-11
WO2002043662A2 (fr) 2002-06-06
MXPA03004817A (es) 2003-09-10

Similar Documents

Publication Publication Date Title
WO2002043659A3 (fr) Composition contenant des statines et du calcium destinee a ameliorer la sante cardiovasculaire
MY162133A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
AU633959B2 (en) Pharmaceutical formulations
AU2001255114A1 (en) Preparation for the prevention and/or treatment of vascular disorders
WO2005110375A8 (fr) Supplément alimentaire pour le traitement des maladies oculaires
DE59803153D1 (de) Fettmischung und dieselben enthaltendes diäteisches oder pharmazeutisches mittel
HK1042240A1 (en) Pharmaceuticals, dietary supplements and cosmetic compositions comprising a fatty acid and ginger
CA2355341A1 (fr) L'utilisation d'ara comme supplement pour une femme qui allaite
WO2006017627A3 (fr) Compositions dietetiques et procedes d'utilisation dans le traitement de l'insulinoresistance
US20080114074A1 (en) Anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
IL117773A0 (en) Solid lipid compositions of coenzyme q10 for enhanced oral bioavailability
US10617700B1 (en) Vitamin supplement compositions with enhanced bioavailability
RU2007117803A (ru) Композиция для лечения глаз, содержащая омега-3 жирные кислоты и омега-6 жирные кислоты
JP2002534445A (ja) 血中コレステロール及び／又は血中トリグリセリドの低下方法
CA2463043A1 (fr) Combinaison d'acide liponique et de glutamine dans des produits alimentaires et pharmaceutiques
WO2006109194A3 (fr) Composes de chrome et d'acides gras et leurs procedes de fabrication et d'utilisation
WO2002043662A3 (fr) Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante
WO2003049687A3 (fr) Compositions medicinales et methodes therapeutiques
US20070009590A1 (en) Physiologically active composition based on phosphatidylserine
US20100239660A1 (en) Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions
WO2003002125A3 (fr) Combinaison de sucres amines et cysteine ou de derives de cysteine
AU604347B2 (en) Nutrient mixture intended for the elderly
JPH04152861A (ja) 栄養補給用栄養組成物
PL367812A1 (en) Alpha-ketoglutarates of active ingredients and compositions containing same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2427681

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002545641

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/004817

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2001998311

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001998311

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642